Dublin, Jan. 28, 2019 (GLOBE NEWSWIRE) -- The "Eastern Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Eastern Equine Encephalitis" report has been added to ResearchAndMarkets.com's offering.

Eastern Equine Encephalitis infection is spread through Clostridium tetani bacteria, which is present in the form of spores in the environment and develops as bacteria upon entering into human body. Painful muscle contractions are the primary symptom and the disease is also referred to as lockjaw' as jaw muscles are tightened in tetanus infected patient.

Different forms of tetanus include- general, local and cephalic tetanus. Sudden spasms of the vocal cords, fractures, infections, aspiration pneumonia are the major complications of the disease.

Despite low costs of treatment, tetanus is rapidly progressing infectious disease, causing mortality. Fourteen companies are currently developing vaccines and treatment options against tetanus infections. The companies in global tetanus pipeline include- Beijing Minhai Biotechnology Co Ltd, BIKEN Corporation, Biological E Ltd, Cadila Healthcare Ltd, Daiichi Sankyo Company, GC Pharma- Korea, GlaxoSmithKline Plc, Indian Immunologicals Ltd, LG Chem Ltd, Olymvax Biopharmaceuticals Inc, Panacea Biotec Ltd, Sanofi, Serum Institute of India Ltd and Wockhardt Ltd.

Report Description:

The Eastern Equine Encephalitis Infection pipeline guide presents complete overview of drugs currently being developed for Eastern Equine Encephalitis Infection. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).

Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Eastern Equine Encephalitis Infection pipeline candidate.
Research and Development progress along with latest news related to each of the Eastern Equine Encephalitis Infection pipeline candidates is included.

Major companies participating in therapeutic development of Eastern Equine Encephalitis Infection are included in this pipeline report. Company wise pre-clinical and clinical products along with details of drug originator, co-developers/ licensors are provided.

Amid strong interest for cure of Eastern Equine Encephalitis Infection from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Eastern Equine Encephalitis Infection clinical and pre-clinical products.

The report assists in identifying potential upcoming companies and drugs in Eastern Equine Encephalitis Infection pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.

Key Topics Covered:

I. Key Findings

1. Companies Investing in Eastern Equine Encephalitis Infection Pipeline include
Number of Companies with Eastern Equine Encephalitis Infection projects in pre-clinical Development
Number of Companies with Eastern Equine Encephalitis Infection projects in Clinical Development

2. Pipeline Candidates include-
Eastern Equine Encephalitis Infection Pipeline Agents in pre- clinical/ Discovery stage of Development
Eastern Equine Encephalitis Infection Pipeline Agents in Clinical Development stage
Eastern Equine Encephalitis Infection Pipeline Therapeutic Compounds received special status
Mechanism of Action of most pipeline Drugs-
Small molecules among the Eastern Equine Encephalitis Infection Pipeline agents

II. Insights into Eastern Equine Encephalitis Infection Pipeline -

1. Disease Overview
Introduction to Eastern Equine Encephalitis Infection
Symptoms and Causes of Eastern Equine Encephalitis Infection
Treatment or Prevention Options for Eastern Equine Encephalitis Infection
Other Details
2. Phase wise Pipeline Compounds
Eastern Equine Encephalitis Infection Pipeline- Pre- Clinical/ Discovery stage Drugs
Eastern Equine Encephalitis Infection Pipeline- Phase 1 stage Drugs
Eastern Equine Encephalitis Infection Pipeline- Phase 2 stage Drugs
Eastern Equine Encephalitis Infection Pipeline- Phase 3 stage Drugs
Eastern Equine Encephalitis Infection Pipeline- Pre-Registration stage Drugs
3. Company wise Eastern Equine Encephalitis Infection Pipeline Compounds
4. Eastern Equine Encephalitis Infection Pipeline by Mechanism of Action

III. Eastern Equine Encephalitis Infection Pipeline Compound Details

• VesiculoVax Prophylactic Vaccines

Drug Details

1. Snapshot
Name of the Therapeutic Agent
Originator
Developing Company
Co-Developer/ License Partner
Orphan Drug / Fast Track/ Designation
Development Phase
2. Drug Overview
3. Mechanism of Action
4. Current Status
5. Clinical Trial Details

IV. Eastern Equine Encephalitis Infection Pipeline Company Briefs

• Bavarian Nordic
• EpiVax Inc
• Profectus BioSciences Inc

V. Latest News and Developments in Global Eastern Equine Encephalitis Infection Pipeline Market

VI. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/gpxcxd/eastern_equine?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Animal Healthcare/Veterinary, Animal Pharmaceuticals 

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.